Safe and effective methylphenidate therapy in a pediatric patient with glaucoma

Case Report
First Online:
Received:
Accepted:

Abstract

Stimulant medications used as first-line treatment in attention deficit hyperactivity disorder (ADHD) are contraindicated in patients with glaucoma. We present the first reported case of using methylphenidate therapy to safely and effectively treat ADHD in a pediatric patient with glaucoma.

Keywords

Attention deficit hyperactivity disorder Glaucoma Stimulant therapy 
This is a preview of subscription content, log in to check access.

References

  1. American Academy of Pediatrics [AAP] Subcommittee on Attention-Deficit Hyperactivity Disorder and Committee on Quality Improvement (2001) Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 108(4):1033–1044CrossRefGoogle Scholar
  2. Aponte EP, Diehl N, Mohney BG (2010) Incidence and clinical characteristics of childhood glaucoma: a population-based study. Arch Ophthalmol 28(4):478–482CrossRefGoogle Scholar
  3. Bartik B, Harmon G, Kaplan F (1997) Use of methylphenidate therapy in a patient with glaucoma and attention-deficit hyperactivity disorder: a clinical dilemma. Arch Gen Psychiatry 54:188–189CrossRefGoogle Scholar
  4. Garnock-Jones KP, Keating GM (2009) Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs 11:203–226PubMedCrossRefGoogle Scholar
  5. Hieble JP, Ruffolo RR Jr (1997) Recent advances in the identification of alpha1- and alpha-2-adrenoceptor subtypes: therapeutic implications. Exp Opin Investig Drugs 6(4):367–387CrossRefGoogle Scholar
  6. Lu CK, Kuang TM, Chou JC (2006) Methylphenidate (Ritalin)-associated cataract and glaucoma. J Chin Med Assoc 69:589–590PubMedCrossRefGoogle Scholar
  7. Pliszka S (2007) Practice parameter for the assessment and treatment of children and adolescents with attention- deficit/hyperactivity disorder. J Am Acad Adolesc Psychiatry 46(7):894–921CrossRefGoogle Scholar
  8. Rappley M (2005) Attention deficit hyperactivity disorder. N Engl J Med 352:165–173PubMedCrossRefGoogle Scholar
  9. Reid WH, Blouin P, Schermer M (1976) A review of psychotropic medications and the glaucomas. Int Pharmacopsychiatry 11(3):163–174PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.Department of PediatricsJoan C. Edwards School of Medicine at Marshall UniversityHuntingtonUSA

Personalised recommendations